Introducing J+D’s Tailored Support Services for Pharmaceutical Forecasting

access to experts.

With decades of experience in the industry and a reputation of delivering excellence to longstanding clients, we are now expanding our resources and services to work as a strategic partner to even more forecasting teams.

Combining best-practice methodologies with the latest approaches, we offer expertise in every pharmaceutical forecasting approach. With this expanded support offering, we can provide outsourced access to our experienced team, so that clients have the right resources precisely when needed. Whether ad-hoc project assistance or long-term support is required, we will work side by side to deliver timely and reliable results, in real time.

“With our established position as industry leaders, we are committed to providing the best forecasting support services that enable pharma and biotech’s to navigate the complexities of the market successfully. It’s an exciting step forward, and we are ready to support our clients in achieving their strategic goals with confidence.”

David James, Founder, J+D Forecasting

choose J+D?

Our diverse talent pool includes technical consultants, pharma forecasting experts, modelers, and analysts. With comprehensive support solutions covering every aspect of your forecasting needs, we can ensure optimal business outcomes by tapping into the various backgrounds and expertise of our team.

With a global reach, and decades of expertise, we are ready to shape the future of forecasting for and with pharmaceutical and biotechnology companies.

Have a support enquiry to discuss? Contact us to learn more and explore how our support services can drive success for your organization. 

Schedule a call

Choose a date and time that works for you.

more insights

Our Pharmaceutical Forecasting Predictions for 2024

As the pharmaceutical industry contends with growing financial pressures, we examine its strategic outlook for 2024. How does the sector intend to align with projected commercial objectives while continuing to meet patient needs and what are the implications for forecasting teams?

Read more >